This inventor holds 19 USPTO granted patents, primarily in Nucleic Acid Therapeutics. Top assignees: Nexstar Pharmaceuticals, Inc., Cortech, Inc., Gilead Sciences, Inc.. Active years: 1993-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 131 
6 out of 40 
4 out of 946 
Years Active: 1993-2007
Areas of Expertise:
Sure, here is an article about inventor Gary P Kirschenheuter:
**Title: The Innovative Work of Gary P Kirschenheuter**
Introduction
Gary P Kirschenheuter, a talented inventor based in Arvada, CO (US), has made significant contributions to the field of biotechnology with his groundbreaking patents and research.
Latest Patents
With an impressive portfolio of 19 patents, Gary P Kirschenheuter has recently been at the forefront of innovative developments in the field. His latest patents include the "Systematic Evolution of Ligands by Exponential Enrichment: Blended SELEX" method and "Urea Nucleosides as Therapeutic and Diagnostic Agents".
Career Highlights
Throughout his career, Gary has worked with companies such as Nexstar Pharmaceuticals, Inc. and Cortech, Inc., where he has spearheaded research projects that have led to transformative discoveries in the field of biotechnology.
Collaborations
Gary P Kirschenheuter has had the privilege of working alongside esteemed colleagues such as Larry M Gold and John C Cheronis, who have contributed to the success of his projects through their expertise and dedication.
Conclusion
In conclusion, Gary P Kirschenheuter's innovative approach to research and his commitment to pushing the boundaries of biotechnology have established him as a pioneering figure in the field. His patents and collaborations stand as a testament to his dedication to advancing science and technology for the betterment of society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile